YLYu Liu

Yu Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yu Liu has a total of 59 co-authors. Here are the top co-authors by number of shared publications:

  • Mengfei Yu

    Department of Stomatology, Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Zhejiang Key Laboratory of Oral Biomedical, Hangzhou, Zhejiang Province, China

    5 shared publications
  • Huiming Wang

    Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Zhejiang Key Laboratory of Oral Biomedical, Hangzhou 310000, China

    3 shared publications
  • Ziyu Zhu

    The Affiliated Hospital of Stomatology School of Stomatology Zhejiang University School of Medicine and Key Laboratory of Oral Biomedical Research of Zhejiang Province Hangzhou Zhejiang China

    3 shared publications
  • Huiming Wang

    Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China

    2 shared publications
  • Jingyu Zhang

    Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Zhejiang Key Laboratory of Oral Biomedical, Hangzhou 310000, China

    2 shared publications
  • Kaizhe Hong

    Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Zhejiang Key Laboratory of Oral Biomedical, Hangzhou 310000, China

    2 shared publications

Latest Publications

  • Engineering Biomimetic Tumor Organoids Inspired by Janus Stiffness–Driven Cell Stemness

    by Ziyu Zhu, Siyi Zhou, Tianyi Gu, Yu Liu, Kuoran Xing, Jiaxing Gong, Lixuen Siow, Yun Jiang, Xin Ye, Kejie Lu, et al.

    Organoids become powerful platforms for modeling cancer biology but poorly preserve stemness due to inadequate biophysical cues. Cancer stem cells (CSCs), crucial for tumor growth, are rare and lose stemness under conventional in vitro conditions, limiting drug screening. While chemical and genetic stemness regulators are identified, the role of spatial matrix mechanics remains unclear and largely absent from current organoid architectures. Here, we demonstrate that stemness depends not on stiffness alone but on 3D spatial stiffness differentials across distinct microenvironmental regions. Single‐cell clustering and spatial localization analyses reveal that CSCs localize at tumor invasive fronts. In vitro mechanobiological studies further identify that Janus stiffness sustains stemness by altering E‐cadherin/β‐catenin interactions, triggering nuclear β‐catenin and stemness programs. Using this insight, we print Janus microsphere sandwiches using a coaxial co‐flow capillary microfluidic device, confining cells between mechanically distinct hydrogel layers to encode cellular‐scale stiffness gradients, a feature unattainable in conventional single‐layer microspheres or bulk‐embedded organoids. This architecture mimics CSC spatial distribution in oral squamous cell carcinoma, maintaining stemness and enabling robust drug screening. By transforming a previously underrepresented mechanobiological mechanism into an engineerable organoid, we create new biomimetic tumor organoid where spatially programmed mechanics, not just biochemistry, governs stemness and therapeutic relevance.

  • Open Access

    At the crossroads of senescence and immunosuppression: Machine learning and multi-omics unveil the central role of FAP in HNSCC

    by Jingyu Zhang, Zhan Yang, Zhixu He, Luying Qin, Yan Tu, Yaxian Luo, Shuangyang Li, Tao Qiu, Kaizhe Hong, Xiaoting Zhang, et al.

  • Digital mandibular reconstruction design guided by condylar position

    by Yemu Yang, Ziyu Zhu, Chuhan Zhang, Desheng Hong, Chengyu Xie, Kaizhe Hong, Luxuan He, Mengfei Yu, Yu Liu

  • Momordicine I induces ER stress and inhibits OSCC by targeting ribosomal proteins

    by Jianlu Kong, Ziyu Zhu, Yijie Hu, Siyi Zhou, Tianyi Gu, Xiao Shen, Huiming Wang, Mengfei Yu, Yu Liu

    Oral squamous cell carcinoma (OSCC) is one of the most common malignant tumors worldwide. This necessitates the development of innovative drugs with high e


  • Open Access

    Cuproptosis-related lncRNA JPX regulates malignant cell behavior and epithelial-immune interaction in head and neck squamous cell carcinoma via miR-193b-3p/PLAU axis

    by Mouyuan Sun, Ning Zhan, Zhan Yang, Xiaoting Zhang, Jingyu Zhang, Lianjie Peng, Yaxian Luo, Lining Lin, Yiting Lou, Dongqi You, et al.

    The development, progression, and curative efficacy of head and neck squamous cell carcinoma (HNSCC) are influenced by complex interactions between epithelial and immune cells. Nevertheless, the specific changes in the nature of these interactions and their underlying molecular mechanisms in HNSCC are not yet fully understood. Cuproptosis, a form of programmed cell death that is dependent on copper, has been implicated in cancer pathogenesis. However, the understanding of cuproptosis in the context of HNSCC remains limited. In this study, we have discovered that cuproptosis-related long non-coding RNAs (CRLs) known as JPX play a role in promoting the expression of the oncogene urokinase-type plasminogen activator (PLAU) by competitively binding to miR-193b-3p in HNSCC. The increased activity of the JPX/miR-193b-3p/PLAU axis in malignant epithelial cells leads to enhanced cell proliferation, migration, and invasion in HNSCC. Moreover, the overexpression of PLAU in tumor epithelial cells facilitates its interaction with the receptor PLAUR, predominantly expressed on macrophages, thereby influencing the abnormal epithelial–immune interactome in HNSCC. Notably, the JPX inhibitor Axitinib and the PLAU inhibitor Palbociclib may not only exert their effects on the JPX/miR-193b-3p/PLAU axis that impacts the malignant tumor behaviors and the epithelial–immune cell interactions but also exhibit synergistic effects in terms of suppressing tumor cell growth and arresting cell cycle by targeting epidermal growth factor receptor (EGFR) and cyclin-dependent kinase (CDK4/6) for the treatment of HNSCC.


  • Open Access

    Odontogenic infections in the antibiotic era: approach to diagnosis, management, and prevention

    by Yiting Lou, Zheyuan Sun, Haiying Ma, Danna Cao, Mouyuan Sun, Qianting Wang, Jingyu Wang, Qunhao Zhuo, Ran Tao, Binbin Ying, et al.

    Purpose The prevalence of odontogenic infections remains one of the highest in the world. If untreated, odontogenic infections can break through the limitation, disseminate to other organs or spaces, and cause high mortality rates. However, it is still difficult to rapidly target limited or disseminated infections in clinical practice. The type of disseminated odontogenic infections and the responsible bacteria have not been described in detail. Methods Search databases (e.g., PubMed, MEDLINE, Web of Science, Embase) for reports published from 2018.1 to 2022.9. Use search strategies: (“odontogenic infections” OR “pulpitis” OR “periapical lesions” OR “periodontal diseases”) AND (“disseminated infections” OR “complication”). Results Fourteen different types of disseminated odontogenic infections, most of which are polymicrobial infections, can spread through the body either direct or through hematogenous diffusion. Multiple microbial infections can be more invasive in the transmission of infection. Secondary infections are commonly associated with bacteria like Fusobacterium spp., Streptococcus spp., Peptostreptococcus spp., Prevotella spp., and Staphylococcus spp. Antibiotics with broad-spectrum activity are fundamental as first-line antimicrobial agents based on the microorganisms isolated from disseminated infections. Conclusion This review elaborates on the epidemiology, microorganisms, risk factors, and dissemination routes, and provides evidence-based opinions on the diagnosis, multidisciplinary management, and prevention of odontogenic infections for dentists and clinicians.


  • Radiographic bone volume alteration after jaw cyst enucleation with or without simultaneous bone grafts: A prospective randomized study

    by Jue Shi, Jinhan Zhou, Chuanxia Liu, Yu Liu, Misi Si

    Objective: This study was aimed to evaluate bone healing after jaw cyst enucleation with or without bone substitutes by cone beam computed tomography, and to analyze potential influence factors for bone formation as well.Materials and Methods: Sixty seven jaw cyst patients were randomly assigned to two groups. Thirty three patients in control group accepted cystectomy without any filling material. The rest 34 bone cavities which filled with xenograft (DBBM, Bio‐Oss®) and covered by absorbable membrane (Bio‐Gide®) were included in the guided bone regeneration (GBR) group. All patients were examined with cone bean computerized tomography before operation, 3 and 6 months after surgery. Linear regression analysis was applied to evaluate the influence factors of bone healing.Results: There was no significant difference in bone formation rate at 3 months after enucleation, with shrinkage rate (SR) of cystic lesion in control group and GBR group of 26.43 ± 14.98% and 20.78 ± 10.80%, respectively (p > 0.05). Larger shrinkage area in GBR group was detected on postoperative radiographs after 6 months with SR of 60.11 ± 19.23%, when compared to those in patients without filling (6 months SR: 48.63 ± 19.39%,p = 0.018, <0.05). Linear regression analysis showed that cyst size was negatively correlated with bone formation.Conclusion: GBR with bovine xenograft and absorbable membrane showed considerable bone regeneration property in the healing of jaw cystic defects after enucleation of radicular cysts. Cyst size showed a suppressive influence on bone formation.